Focus on type 2 diabetes, metabolic syndrome and cardiovascular risk

被引：0
|
作者：
机构：
来源：
POST ACCORD PERSPECTIVES: THE ROLE OF FENOFIBRATES: TRANSLATING THE EVIDENCE-BASED MEDICINE AND SCIENCE INTO CLINICAL PRACTICE FOR THE PRIMARY CARE PROVIDER | 2010年 / 274卷
关键词：
INSULIN-RESISTANCE; DISEASE; MORTALITY; MELLITUS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：20 / 25
页数：6
相关论文
共 50 条
  • [21] Impacts of the metabolic syndrome and Framingham risk score on cardiovascular predictors in patients with type 2 diabetes
    Koh, G.
    Lim, D. -M.
    Park, K. -Y.
    Lee, D. -H.
    Chin, H. -J.
    Lee, J. -M.
    DIABETOLOGIA, 2006, 49 : 700 - 700
  • [22] Cardiovascular disease prediction and type 2 diabetes:: Framingham risk versus metabolic syndrome criteria
    Saumell, J.
    Cabre, J. J.
    Pinol, J. L.
    Baldrich, M.
    Martin, F.
    Costa, B.
    Basora, J.
    DIABETOLOGIA, 2007, 50 : S147 - S147
  • [23] Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients
    Riquelme-Gallego, Blanca
    Garcia-Molina, Laura
    Cano-Ibanez, Naomi
    Sanchez-Delgado, Guillermo
    Andujar-Vera, Francisco
    Garcia-Fontana, Cristina
    Gonzalez-Salvatierra, Sheila
    Garcia-Recio, Enrique
    Martinez-Ruiz, Virginia
    Bueno-Cavanillas, Aurora
    Munoz-Torres, Manuel
    Garcia-Fontana, Beatriz
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [24] Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients
    Blanca Riquelme-Gallego
    Laura García-Molina
    Naomi Cano-Ibáñez
    Guillermo Sánchez-Delgado
    Francisco Andújar-Vera
    Cristina García-Fontana
    Sheila González-Salvatierra
    Enrique García-Recio
    Virginia Martínez-Ruiz
    Aurora Bueno-Cavanillas
    Manuel Muñoz-Torres
    Beatriz García-Fontana
    Scientific Reports, 10
  • [25] Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?
    Stern, MP
    Williams, K
    González-Villalpando, C
    Hunt, KJ
    Haffner, SM
    DIABETES CARE, 2004, 27 (11) : 2676 - 2681
  • [26] Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome
    Meigs, James B.
    Rutter, Martin K.
    Sullivan, Lisa M.
    Fox, Caroline S.
    D'Agostino, Ralph B., Sr.
    Wilson, Peter W. F.
    DIABETES CARE, 2007, 30 (05) : 1219 - 1225
  • [27] The ORListat and cardiovascular risk profile in patients with metabolic syndrome and type 2 Diabetes (ORLICARDIA) study
    Didangelos, TP
    Thanopoulou, AK
    Bousboulas, SH
    Sambanis, CL
    Athyros, VG
    Spanou, EA
    Dimitriou, KC
    Pappas, SI
    Karamanos, BG
    Karamitsos, DT
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (09) : 1393 - 1401
  • [28] Adipocytokines, Metabolic Syndrome and Cardiovascular Risk in Patients With Type 2 Diabetes and Chronic Hepatitis C
    Dragut, Ramona Maria
    Rusu, Emilia
    Parpala, Cristina
    Nan, Raluca
    Rusu, Florin
    Popescu, Horatiu
    Tocaci, Georgiana
    Radulian, Gabriela
    DIABETES, 2013, 62 : A598 - A598
  • [29] Polymorphisms in Kalirin are associated with type 2 diabetes, metabolic syndrome and measures of cardiovascular risk in the diabetes heart study
    Rudock, Megan E.
    Ziegler, Julie T.
    Lehtinen, Allison B.
    Freedman, Barry I.
    Carr, J. J.
    Langefeld, Cardl D.
    Bowden, Donald W.
    DIABETES, 2008, 57 : A42 - A43
  • [30] Metabolic Syndrome, Diabetes, and Cardiovascular Risk in HIV
    Nix, Linda M.
    Tien, Phyllis C.
    CURRENT HIV/AIDS REPORTS, 2014, 11 (03) : 271 - 278
12345